Article PDF
Avoid common mistakes on your manuscript.
References
Fergusson D, Khanna MP, Tinmouth A, Hebert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized clinical trials. Can J Anesth 2004; 51: 417–24.
Boomgaard MN, Gouwerok CW, Palfenier CH, et al. Pooled platelet concentrates prepared by the plateletrich-plasma method and filtered with three different filters and stored for 8 days. Vox Sang 1995; 68: 82–9.
Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997; 63: 964–7.
Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84: 1703–21.
Brecher ME, Pineda AA, Torloni AS, et al. Prestorage leukocyte depletion: effect on leukocyte and platelet metabolites, erythrocyte lysis, metabolism, and in vivo survival. Semin Hematol 1991; 28(3 Suppl 5): 3–9.
Heddle NM, Soutar RL, O’Hoski PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91: 1000–5.
Smith KJ, Sierra ER, Nelson EJ. Histamine, IL-1, and IL-8 increase in packed RBCs stored for 42 days, but not in RBCs leukodepleted pre-storage. Transfusion 1993; 33: 53S.
Blajchman MA, Bardossy L, Carmen R, et al. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993; 81: 1880–2.
Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994; 84: 344–8.
Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplantation Proceedings 1973; 5: 253–9.
Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against. Transfusion 2001; 41: 691–712.
Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513–6.
Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996; 83: 973–7.
van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97: 562–8.
Fergusson D, Hebert PC, Lee SK, et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA 2003; 289: 1950–6.
Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289: 1941–9.
Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417–21.
Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721–9.
Fung MK, Rao N, Rice J, et al. Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study. Transfusion 2004; 44: 30–5.
King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile non-hemolytic transfusion reactions to RBCs. Transfusion 2004; 44: 25–9.
Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44: 16–24.
Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44: 10–5.
Klein HG. Will blood transfusion ever be safe enough? JAMA 2000; 284: 238–40.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by grant from the National Heart Lung and Blood Institute 1 R01 HL73958-01.
Rights and permissions
About this article
Cite this article
Carson, J.L., Berlin, J.A. Will we ever know if leukoreduction of red blood cells should be performed?. Can J Anesth 51, 407–410 (2004). https://doi.org/10.1007/BF03018300
Issue Date:
DOI: https://doi.org/10.1007/BF03018300